Микробиом кожи при атопическом дерматите и особенности различных средств базисного ухода за кожей

СтатьяМЕД СОВЕТ. 2018; № 2: 170–176. DOI:10.21518/2079-701X-2018-2-170-176

Заславский Д.В.^[1]

Баринова А.Н.^[2]

^[1]Санкт-Петербургский государственный педиатрический медицинский университет

^[2]Северо-Западный государственный медицинский университет им. И. И. Мечникова (Санкт-Петербург)

В последние годы наблюдается рост заболеваемости атопического дерматита у детей. В данной статье авторы приводят литературный обзор микробиома кожи при атопическом дерматите, фармакологические особенности различных средств базисного ухода за кожей.

микробиом

эмоленты

смягчающие

атопический дерматит

профилактика

микробиом

атопический дерматит

строфулюс

лечение

профилактика

Воски

Глицерин

Дети

Заболеваемость

Масла

Микробиота

Обзор

Пропиленгликоль

Рост

Стафилококки

Экзема

Эмоленты

Эпидермис

Заславский Д.В., Новикова В.П., Чупров И.Н., Сыдиков А.А., Хведелидзе М.Г., Татарская О.Б. Пробиотики в профилактике и терапии атопического дерматита у детей. Вопросы практической педиатрии, 2016, 11(2): 51-57.

Кубанова А.А., Кубанов А.А., Мелехина Л.Е., Богданова Е.В. Анализ состояния заболеваемости болезнями кожи и подкожной клетчатки в Российской Федерации за период 2003– 2016 гг. Вестник дерматологии и венерологии, 2017, 6: 22–33.

Горланов И.А., Милявская И.Р., Леина Л.М., Заславский Д.В., Оловянишников О.В., Куликова С.Ю. Детская дерматовенерология. М.: ИГ ГЕОТАР-Медиа, 2017. 512 с.

Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015.

Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, et al. Topographical and temporal diversity of the human skin microbiome. Science, 2009, 324(5931): 1190-2.

Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proceedings of the National Academy of Sciences of the United States of America, 2008, 105(46): 17994-9.

Shi B, Bangayan NJ, Curd E, Taylor PA, Gallo RL, Leung DY, et al. The skin microbiome is different in pediatric versus adult atopic dermatitis. J Allergy Clin Immunol, 2016, 138(4): 1233-6.

Rosenthal M, Aiello A, Larson E, Chenoweth C, Foxman B. Healthcare workers’ hand microbiome may mediate carriage of hospital pathogens. Pathogens, 2013, 3(1): 1-13.

Callewaert C, Hutapea P, Van de Wiele T, Boon N. Deodorants and antiperspirants affect the axillary bacterial community. Arch Dermatol Res, 2014, 306(8): 701-10.

Leyden JJ, Marples RR, Kligman AM. Staphylococcus aureus in the lesions of atopic dermatitis. The British journal of dermatology, 1974, 90(5): 525-30

Totte JE, van der Feltz WT, Hennekam M, van Belkum A, van Zuuren EJ, Pasmans SG. Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis. Br J Dermatol, 2016, 175(4):687–95.

Darabi K, Hostetler SG, Bechtel MA, Zirwas M. The role of Malassezia in atopic dermatitis affecting the head and neck of adults. Journal of the American Academy of Dermatology, 2009, 60(1): 125-36.

Ward DM, Weller R, Bateson MM. 16S rRNA sequences reveal numerous uncultured microorganisms in a natural community. Nature, 1990, 345(6270): 63-5.

Bieber T. Mechanisms of disease: Atopic dermatitis. New England Journal of Medicine, 2008, 358(14): 1483-94.

Oh J, Freeman AF, Park M, Sokolic R, Candotti F, Holland SM, et al. The altered landscape of the human skin microbiome in patients with primary immunodeficiencies. Genome Research, 2013, 23(12): 2103-14.

Kong HDH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Research, 2012, 22(5): 850-9.

Bourrain M, Ribet V, Calvez A, Lebaron P, Schmitt AM. Balance between beneficial microflora and Staphylococcus aureus colonisation: in vivo evaluation in patients with atopic dermatitis during hydrotherapy. Eur J Dermatol, 2013, 23(6): 786-94.

Seite S, Flores GE, Henley JB, Martin R, Zelenkova H, Aguilar L, et al. Microbiome of affected and unaffected skin of patients with atopic dermatitis before and after emollient treatment. J Drugs Dermatol, 2014, 13(11): 1365-72.

Gonzalez ME, Schaffer JV, Orlow SJ, Gao Z, Li H, Alekseyenko AV, et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol, 2016, 75(3): 481-93.

Dekio I, Sakamoto M, Hayashi H, Amagai M, Suematsu M, Benno Y. Characterization of skin microbiota in patients with atopic dermatitis and in normal subjects using 16S rRNA genebased comprehensive analysis. J Med Microbiol, 2007, 56(Pt 12): 1675-83.

Chng KR, Tay ASL, Li C, Ng AHQ, Wang J, Suri BK, et al. Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare. Nature Microbiology, 2016, 1(9).

Zhang E, Tanaka T, Tajima M, Tsuboi R, Nishikawa A, Sugita T. Characterization of the skin fungal microbiota in patients with atopic dermatitis and in healthy subjects. Microbiol Immunol, 2011, 55(9): 625-32.

Rodrigues Hoffmann A, Patterson AP, Diesel A, Lawhon SD, Ly HJ, Elkins Stephenson C, et al. The skin microbiome in healthy and allergic dogs. PloS One, 2014, 9(1): e83197.

Bradley CW, Morris DO, Rankin SC, Cain CL, Misic AM, Houser T, et al. Longitudinal Evaluation of the Skin Microbiome and Association with Microenvironment and Treatment in Canine Atopic Dermatitis. J Invest Dermatol, 2016 Jun, 136(6):1182-90. doi: 10.1016/j.jid.2016.01.023. Epub 2016 Feb 6..
DOI: 10.1016/j.jid.2016.01.023. Epub 2016 Feb 6

Kobayashi T, Glatz M, Horiuchi K, Kawasaki H, Akiyama H, Kaplan DH, et al. Dysbiosis and Staphylococcus aureus Colonization Drives Inflammation in Atopic Dermatitis. Immunity, 2015, 42(4): 756-66.

Scharschmidt TC, List K, Grice EA, Szabo R, Renaud G, Lee CC, et al. Matriptasedeficient mice exhibit ichthyotic skin with a selective shift in skin microbiota. J Invest Dermatol, 2009, 129(10): 2435-42.

Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol, 2014, 134(4): 818-23.

Glatz M, Polley EC, Simpson EL, Kong HH. Emollient therapy alters skin barrier and microbes in infants at risk for developing atopic dermatitis. Journal of Investigative Dermatology, 2015, 135: S31.

Gueniche A, Knaudt B, Schuck E, Volz T, Bastien P, Martin R, et al. Effects of nonpathogenic gram-negative bacterium Vitreoscilla filiformis lysate on atopic dermatitis: A prospective, randomized, double-blind, placebo-controlled clinical study. British Journal of Dermatology, 2008, 159(6): 1357-63.

Mark R. How to measure the effects of emollients. J Dermatolog Treat, 1997, 8(Suppl 1): 15–18

Lawton S. Skin barrier function and the use of emollients in dermatological nurs-ing. Br J Nurs, 2007, 16(12): 712-719.

Cork MJ. Complete emollient therapy. In: The National Association of Fund-holding Practices Official Year Book. BPC Waterlow, Dunstable, 1998.

Finlay AY. Emollients as adjuvant therapy for psoriasis. J Dermatolog Treat, 1997, 8(Suppl 1): 25–27.

Peters J. Caring for dry and damaged skin in the community. Br J Community Nurs, 2001, 6(12): 645–651.

Grove G, Zerweck C, Houser T, Andrasfay A, Gauthier B, Holland C, Piac-quadio D. Halobetasol Propionate Lotion, 0.05[%] Provides Superior Hydration Compared to Halobetasol Propionate Cream, 0.05[%] in a Double-Blinded Study of Occlusivity and Hydration. J Drugs Dermatol, 2017 Feb 1, 16(2): 140-144.

Pringle F, Penzer R (2002) Normal skin: its function and care. In: Penzer R, ed. Nursing Care of the Skin. Butterworth-Heinemann, London, 2002: 20–45.

Ridd MJ, Garfield K, Gaunt DM, Hollinghurst S, Redmond NM, Powell K, Wil-son V, Guy RH, Ball N, Shaw L, Purdy S, Metcalfe C. Choice of Moisturiser for Eczema Treatment (COMET): feasibility study of a randomised controlled paral-lel group trial in children recruited from primary care. BMJ Open, 2016, 6(11): e012021.

Lindh JD, Bradley M. Clinical Effectiveness of Moisturizers in Atopic Dermatitis and Related Disorders: A Systematic Review. Am J Clin Dermatol, 2015 Oct, 16(5): 341-59.

Simpson EL, Chalmers JR, Hanifin JM, Thomas KS, Cork MJ, McLean WH, Brown SJ, Chen Z, Chen Y, Williams HC. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol, 2014 Oct, 134(4): 818-823.

Martini J, Huertas C, Turlier V, Saint-Martory C, Delarue A. Efficacy of an emollient cream in the treatment of xerosis in diabetic foot: a double-blind, ran-domized, vehicle-controlled clinical trial. J Eur Acad Dermatol Venereol, 2017 Apr, 31(4): 743-747.

Federici A, Federici G, Milani M. An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerolbased emol-lient cream. A randomized, assessor-blinded, controlled trial. BMC Dermatol, 2012, 12: 16.

van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emol-lients and moisturisers for eczema. Cochrane Database Syst Rev, 2017, 2: CD012119.

van Zuuren EJ, Fedorowicz Z, Arents BWM. Emollients and moisturizers for ec-zema: abridged Cochrane systematic review including GRADE assessments. Br J Dermatol, 2017, 177(5): 1256-1271.

Allen H. et al. The presence and impact of Biofilm-Producing Staphylococci in Atopic Dermatitis JAMA, 2014, 150(3): 260-265.

Societe Francaise de dermatologie. Prise en charge de la dermatite atopique de l’enfant. Conference de consensus. Conference pleniere le Mercredi 20 Octobre 2004, Institut Pasteur, Paris. Texte des recommendations (version texte court).

Язык текста: Русский

ISSN: 2079-701X